Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 61 Carcinoma, Renal Cell 39 Neoplasm Metastasis 38 Neoplasms 24 Kidney Neoplasms 20 Neuroendocrine Tumors 19 Recurrence 16 Prostatic Neoplasms 15 Head and Neck Neoplasms 13 Tuberous Sclerosis 12 Triple Negative Breast Neoplasms 12 Lymphoma, Mantle-Cell 11 Hodgkin Disease 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma 10 Colorectal Neoplasms 10 Waldenstrom Macroglobulinemia 9 Stomach Neoplasms 9 Multiple Myeloma 9 Leukemia, Lymphocytic, Chronic, B-Cell 9 Glioma 9 Glioblastoma 9 Brain Neoplasms 9 Sarcoma 8 Pancreatic Neoplasms 8 Melanoma 8 Lymphoma, Follicular 8 Lung Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8

Interventions

Megestrol Acetate 7 Progestins 3 Medroxyprogesterone Acetate 3 Progesterone 2 Letrozole 2 Hysteroscopy 2 Blood Specimen Collection 2 Biopsy 2 Atorvastatin 2 semaglutide 1 ricin A-GnRH conjugate 1 estradiol, norethindrone drug combination 1 Tirzepatide 1 Tamoxifen 1 Surveys and Questionnaires 1 Sampling Studies 1 Rosuvastatin Calcium 1 Restraint, Physical 1 Resistance Training 1 Pterocarpus marsupium 1 Observation 1 Nutrition Assessment 1 Metformin 1 Magnetic Resonance Spectroscopy 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Intrauterine Devices 1 Immunohistochemistry 1 Hysterectomy 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Gonadotropin-Releasing Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Endometrial Hyperplasia × Everolimus × Clear all

NCT02397083 2026-02-13

LEVER

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡